Interview: Akari's Coversin Ticking Along Nicely

Phase II Trial Shows Promise For Rare Skin Disorder

 
• By Kevin Grogan
  
Ticks
Coversin is derived from a protein discovered in the saliva of the Ornithodoros moubata tick • Source: Akari Therapeutics
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Scrip